Neulasta
Links shared publicly online about this topic
Timing of Neulasta and preventing opioid-induced constipation - ONA
oncologynurseadvisor.com — “This month's questions: Giving Neulasta on the day of chemotherapy and strategies for managing opioid induced constipation.” View full resource at oncologynurseadvisor.com
Most Recently Shared on September 2, 2010 at 4:48 pm By:
Timing of Neulasta and preventing opioid-induced constipation http://goo.gl/fb/nFDFB
MediGuard.org - Neulasta | Drug safety information | Monitoring several patients
mediguard.org — “MediGuard.org - Neulasta | Drug safety information | Monitoring several patients” View full resource at mediguard.org
Most Recently Shared on February 28, 2011 at 4:17 pm By:
MediGuard is tracking how well #neulasta works in over 28 patients: http://tinyurl.com/4g685yc
Copying biotech medicine attracts more drugmakers | Reuters
reuters.com — “* Branded makers consider entering biosimilars arena* Amgen, Biogen exploring biosimilars* Merck has Neupogen, Neulasta biosimilar trials underwayBy Deena BeasleySAN FRANCISCO, Jan 13 (Reuters)” View full resource at reuters.com
Most Recently Shared on January 18, 2011 at 2:22 pm By:
More drugmakers consider making cheaper copies of biologic medicines. (Reuters) http://reut.rs/h5m4hR #SITT
Pegfilgrastim to accelerate neutrophil engraftment... [Leuk Lymphoma. 2011] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on February 18, 2011 at 11:47 pm By:
Neulasta helps myeloma patients recover neutrophils more quickly after stem cell transplantation that Neupogen (http://bit.ly/fxOwho).
The Weekly Summary | CurrentMedicine.tv
currentmedicine.tv — “May 23rd - May 30th In the general news, European debt worries were in focus again as Greece is still unable to pay the bills, despite bailouts. In the” View full resource at currentmedicine.tv
Most Recently Shared on May 30, 2011 at 3:21 pm By:
The Weekly Summary is now posted http://tinyurl.com/3e8thkj New Hep C drug, JNJ analyst day, the AMA is selling you out, cuts to Neulasta
Neupogen - Page 2 - Nursing for Nurses
allnurses.com — “IDK if this matters or not- BUT I got Neupogen (or Neulasta) only on the weekends, since I had to resume chemo on Mondays. The doc wanted the Neupogen” View full resource at allnurses.com
Most Recently Shared on November 9, 2011 at 12:27 am By:
Neupogen: Hi, I am an new RN and just got hired into a chemotherapy clinic. First off, it is sink or... http://t.co/hmgIsT89
Copying biotech medicine attracts more drugmakers | Reuters
uk.reuters.com — “* Branded makers consider entering biosimilars arena * Amgen, Biogen exploring biosimilars * Merck has Neupogen, Neulasta biosimilar trials underway By Deena Beasley SAN FRANCISCO, Jan 13 (Reuters)” View full resource at uk.reuters.com
Most Recently Shared on January 14, 2011 at 2:02 pm By:
Now Biogen Idec says that it wants to get into biosimilars. Joins with Merck/Amgen. Every major player is getting in. http://reut.rs/gqXf2X
Why Blog on OncotypeDx and BC Pathology? | Medical Lessons
medicallessons.net — “I can't even begin to think of how much money this might save, besides sparing so many women from the messy business of infusions, temporary or semi-permanent IV catheters, prophylactic and urgent antibiotics, Neulasta injections, anti-nausea drugs, cardiac tests and then some occasional deaths in treatment from infection, bleeding or, later on, from late effects on the heart or not-so-rare secondary malignancies like leukemia. And hairpieces; we could see a dramatic decline in women with scarve” View full resource at medicallessons.net
Most Recently Shared on May 21, 2010 at 6:03 pm By:
Why blog on breast cancer pathology? So women can make informed decisions on adjuvant chemo for early-stage disease - http://wp.me/pNmKG-Mu
Summary Box: Amgen profit falls in 3Q
health.yahoo.net — “FLAT VICTORY: Biotech drugmaker Amgen Inc. said Monday its third-quarter profit fell because of flat sales and higher operating costs, although the drugmaker still beat expectations.” View full resource at health.yahoo.net
Most Recently Shared on October 25, 2010 at 10:41 pm By:
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
-
MediGuard.org
Live health insights from 2.5+ million users of MediGuard, the easiest way to get safety alerts and recalls for your medicines.
-
ScienceintheTriangle
Science writer, blogger, former N&O biotech and pharma reporter
Advertisement

